Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

GDF1 Is a Regulator of Sphingolipid Metabolism in Acute Myeloid Leukemia

Weiyuan Wang, Emily Sullivan, Vasiliki Papakotsi, Andrea Cote, Paul Toran, PhD, Thomas P Loughran, Jr., MD, Brian Barth, PhD MS, BS

Blood (2019) 134 (Supplement_1): 1245.

https://doi.org/10.1182/blood-2019-130964

Published: 2019

Journal Articles

Predicting Induction Toxicity with 7+3: Analysis of SWOG Trial S1203

Megan Othus, PhD, Guillermo Garcia-Manero, MD, Frederick R. Appelbaum, MD, Harry P. Erba, MD PhD, Roland B. Walter, MDPhDMS

Blood (2018) 132 (Supplement 1): 1403.

https://doi.org/10.1182/blood-2018-99-117565

Published: 2018

Journal Articles

Genetic Characterization Of Williams Beuren Syndrome Associated With Non-Hodgkin Lymphoma

David Guenat, Carmelo Rizzari, MD, PhD, Patrick Edery, MD, PhD, Jean Soulier, MD, PhD, Christophe Ferrand, PhD, Christophe Borg, MD, PhD, Pierre-Simon Rohrlich, MD, PhD

Blood (2013) 122 (21): 4898.

https://doi.org/10.1182/blood.V122.21.4898.4898

Published: 2013

Journal Articles

A “Master Regulatory Cis -element” Governs the Hematopoietic Stem/Progenitor Cell Compartment, Vascular Integrity, and Cardiovascular Development

Kirby D Johnson, Myung-Jeom Ryu, Meghan E Boyer, Sunduz Kelez, Jing Zhang, Youngsook Lee, Emery H Bresnick, PhD

Blood (2011) 118 (21): 1304.

https://doi.org/10.1182/blood.V118.21.1304.1304

Published: 2011

Journal Articles

Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML

Elspeth M. Payne, Niccolò Bolli, Jennifer Rhodes, Omar I. Abdel-Wahab, Ross Levine, Cyrus V. Hedvat, Richard Stone, Arati Khanna-Gupta, Hong Sun, John P. Kanki, Hanna T. Gazda, Alan H. Beggs, Finbarr E. Cotter, A. Thomas Look

Blood (2011) 118 (4): 903–915.

https://doi.org/10.1182/blood-2010-11-318022

Published: 2011

Includes: Multimedia, Supplemental data

Journal Articles

Final Results From a Pivotal, Multicenter, International, Open-Label, Phase 2 Study of Romidepsin In Progressive or Relapsed Peripheral T-Cell Lymphoma (PTCL) Following Prior Systemic Therapy

Bertrand Coiffier, MD, PhD, Barbara Pro, MD, H. Miles Prince, MD, FRACP, FRCPA, Francine M Foss, MD, Lubomir Sokol, MD, PhD, Matthew Greenwood, MD, FRCPA, FRACP, Dolores Caballero, MD, Peter Borchmann, MD, Franck Morschhauser, MD, PhD, Martin Wilhelm, MD, Lauren Pinter-Brown, MD, Swaminathan Padmanabhan, MD, Andrei Shustov, MD, Jean Nichols, Susan Carroll, John Balser, PhD, Steven M Horwitz, MD

Blood (2010) 116 (21): 114.

https://doi.org/10.1182/blood.V116.21.114.114

Published: 2010

Journal Articles

Effect of Phlebotomy Therapy On Hemoglobin Concentration and Tricuspid Regurgitation Velocity in Chuvash Polycythemia.

Galina Y Miasnikova, MD, Xiaomei Niu, MD, Mehdi Nouraie, MD, PhD, Adelina I Sergueeva, MD, Daniel J Okhotin, MS, Tatiana Ammosova, PhD, Sergei Nekhai, PhD, Zakari Aliyu, MD, MPH, MSc, Craig Sable, MD, Niti Dham, MD, Victor R. Gordeuk, MD

Blood (2009) 114 (22): 1897.

https://doi.org/10.1182/blood.V114.22.1897.1897

Published: 2009

Journal Articles

Clinically Significant Responses Achieved with Romidepsin in 37 Patient with Cutaneous T-Cell Lymphoma (CTCL) with Blood Involvement.

Youn H Kim, MD, Marie-France Demierre, MD, Ellen J Kim, MD, Alain H Rook, MD, Adam Lerner, MD, Madeleine Duvic, MD, Sunil Reddy, MD, Tadeusz Robak, MD, PhD, Jürgen C Becker, MD, Alexey Samtsov, MD, William McCulloch, MB, FRCP, Sean Whittaker, MD, FRCP

Blood (2009) 114 (22): 2683.

https://doi.org/10.1182/blood.V114.22.2683.2683

Published: 2009

Journal Articles

Characterization of Cyclic Hematologic Changes Observed in Patients with Cutaneous T-Cell Lymphoma (CTCL) Receiving Romidepsin, a Novel Histone Deacetylase (HDAC) Inhibitor.

Sean Whittaker, MD, FRCP, Ellen J Kim, MD, Miles Prince, Marie France Demierre, MD, Cynthia Giver, Sagar Lonial, MD, Richard Piekarz, MD, PhD, Youn H Kim, MD, Jean Nichols, PhD, Darrell Nix, Ph.D., Susan Bates, MD

Blood (2009) 114 (22): 3701.

https://doi.org/10.1182/blood.V114.22.3701.3701

Published: 2009

Journal Articles

Phase II Trial of Oral Panobinostat (LBH589) in Patients with Refractory Cutaneous T-Cell Lymphoma (CTCL).

Madeleine Duvic, Jürgen C. Becker, Stephane Dalle, Francisco Vanaclocha, Maria Grazia Bernengo, Celeste Lebbé, Reinhard Dummer, Samit Hirawat, Lei Zhang, Miriam Marshood, Glen Laird, H. Miles Prince

Blood (2008) 112 (11): 1005.

https://doi.org/10.1182/blood.V112.11.1005.1005

Published: 2008

Journal Articles

Clinically Significant Responses Achieved with Romidepsin in Treatment-Refractory Cutaneous T-Cell Lymphoma: Final Results from a Phase 2B, International, Multicenter, Registration Study

Youn Kim, MD, Sean Whittaker, MD, FRCP, Marie France Demierre, MD, Alain H Rook, MD, Adam Lerner, MD, Madeleine Duvic, MD, Sunil Reddy, MD, Ellen J Kim, MD, Tadeusz Robak, MD, Jürgen C Becker, MD, Alexey Samtsov, MD, William McCulloch, MB, FRCP, Archibald G Prentice, MBChB, FRCP, FRCPath

Blood (2008) 112 (11): 263.

https://doi.org/10.1182/blood.V112.11.263.263

Published: 2008

Journal Articles

Treatment of Iron-Deficiency Anemia with IV Ferumoxytol in CKD Patients: Efficacy Compared with Oral Iron across Different Age Groups.

Louis Brenner, MD, Paul Miller, Sally Rodriguez, Nainesh Parikh, Daniel W. Coyne, MD

Blood (2007) 110 (11): 2679.

https://doi.org/10.1182/blood.V110.11.2679.2679

Published: 2007

Journal Articles

Romidepsin (Depsipeptide, FK228) Induces Clinically Significant Responses in Treatment-Refractory CTCL: Interim Report of a Phase II Multicenter Study.

Adam Lerner, M.F. Demierre, S. Whittaker, T. Robak, E. Baran, W. McCulloch, A.G. Prentice

Blood (2006) 108 (11): 2468.

https://doi.org/10.1182/blood.V108.11.2468.2468

Published: 2006

Journal Articles

Natural Killer Cell Changes To Moderate Exercise on Arterial Compliance and Autonomic Modulation in Patients with Human Immunodeficiency Virus-1 (HIV-1).

D.K. Spierer, MA, PhD, Eugene McPherson, MD, PhD, J.I.M. Kleinfeld, MD, E. Hazel, MD

Blood (2004) 104 (11): 3838.

https://doi.org/10.1182/blood.V104.11.3838.3838

Published: 2004

NARROW

GDF1 Is a Regulator of Sphingolipid Metabolism in Acute Myeloid Leukemia

Predicting Induction Toxicity with 7+3: Analysis of SWOG Trial S1203

Genetic Characterization Of Williams Beuren Syndrome Associated With Non-Hodgkin Lymphoma

A “Master Regulatory Cis -element” Governs the Hematopoietic Stem/Progenitor Cell Compartment, Vascular Integrity, and Cardiovascular Development

Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML

Final Results From a Pivotal, Multicenter, International, Open-Label, Phase 2 Study of Romidepsin In Progressive or Relapsed Peripheral T-Cell Lymphoma (PTCL) Following Prior Systemic Therapy

Effect of Phlebotomy Therapy On Hemoglobin Concentration and Tricuspid Regurgitation Velocity in Chuvash Polycythemia.

Clinically Significant Responses Achieved with Romidepsin in 37 Patient with Cutaneous T-Cell Lymphoma (CTCL) with Blood Involvement.

Characterization of Cyclic Hematologic Changes Observed in Patients with Cutaneous T-Cell Lymphoma (CTCL) Receiving Romidepsin, a Novel Histone Deacetylase (HDAC) Inhibitor.

Phase II Trial of Oral Panobinostat (LBH589) in Patients with Refractory Cutaneous T-Cell Lymphoma (CTCL).

Clinically Significant Responses Achieved with Romidepsin in Treatment-Refractory Cutaneous T-Cell Lymphoma: Final Results from a Phase 2B, International, Multicenter, Registration Study

Treatment of Iron-Deficiency Anemia with IV Ferumoxytol in CKD Patients: Efficacy Compared with Oral Iron across Different Age Groups.

Romidepsin (Depsipeptide, FK228) Induces Clinically Significant Responses in Treatment-Refractory CTCL: Interim Report of a Phase II Multicenter Study.

Natural Killer Cell Changes To Moderate Exercise on Arterial Compliance and Autonomic Modulation in Patients with Human Immunodeficiency Virus-1 (HIV-1).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only